[Form 4] MAIA Biotechnology, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MAIA Biotechnology director Stan Smith reported an award of stock options as compensation. On March 31, 2026, an entity associated with him, The Stan V. Smith Trust Dated 1993, received 33,099 stock options under MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan.
The options give the right to buy an equal number of shares of common stock at an exercise price of $1.40 per share. They vest 100% on the grant date and are exercisable beginning that day, expiring on March 31, 2036. After this grant, the filing shows 33,099 options indirectly beneficially owned.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Smith Stan
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 33,099 | $0.00 | -- |
Holdings After Transaction:
Stock Options — 33,099 shares (Indirect, See footnote)
Footnotes (1)
- The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
Key Figures
Options granted: 33,099 options
Exercise price: $1.40 per share
Expiration date: March 31, 2036
+2 more
5 metrics
Options granted
33,099 options
Stock options granted on March 31, 2026
Exercise price
$1.40 per share
Strike price for MAIA common stock
Expiration date
March 31, 2036
Option term under 2021 Equity Incentive Plan
Post-transaction options held
33,099 options
Total derivative securities following transaction
Vesting
100% on grant date
Options vest fully on March 31, 2026
Key Terms
Stock Options, 2021 Equity Incentive Plan, beneficially owned, indirect ownership, +1 more
5 terms
Stock Options financial
"The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
2021 Equity Incentive Plan financial
"granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan"
beneficially owned financial
"These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
indirect ownership financial
"total_shares_following_transaction 33099.0000, direct_or_indirect I, nature_of_ownership See footnote"
exercise price financial
"conversion_or_exercise_price 1.4000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
